Chen Liang, PhD
HIV
COVID-19
SARS-CoV
innate immunity
interferon
About Us
|
|
---|
Research
|
|
---|
Services
|
|
---|
Displaying 20 result(s).
Chen Liang, PhDHIV COVID-19 SARS-CoV innate immunity interferon |
Michael Libman, MDtropical diseases parasitology travel medicine epidemiology |
Ivan Litvinov, MD, PhD, FRCPCBasal cell carcinoma cutaneous T-cell lymphoma gene expression profiling oncolytic viruses cancer epidemiology CTB |
Jun-Li Liu, PhDCCN5/WISP2 pancreatic islets growth and development transgenic mice knockout mice CTB |
Sampath Loganathan, PhDhead and neck squamouse cell carcinoma in vivo CRISPR screens cancer cell signaling drug targets CTB |
Vivian Loo, MD, M.Sc.Clostridium difficile healthcare-associated infections infection control |
Nancy Low, MD, M.Sc., FRCPCmood bipolar anxiety stress family |
Ilka Lowensteyn, PhDCardiac rehabilitation exercise physiology kinesiology prevention wellness |
Andréanne Lupien, PhDtuberculosis non-tuberculous mycobacteria drug development tuberculosis preventive treatment drug resistance CTB |
Judy Luu, MD, PhDwomen's heart health cardiac MRI ischemic heart disease healthcare disparities equity/diversity/inclusion CORE |
Mary Ellen Macdonald, PhDoral health death dying and bereavement health professions education |
Sheldon Magder, MDVascular biology endothelial function nitric oxide estrogen oxygen radicals |
Jacek Majewski, PhDBioinformatics genomics |
Annette Majnemer, OT, M.Sc., PhDchildhood disability outcomes determinants rehabilitation knowledge translation CORE |